Pharmacological modification of multi‐drug resistance (mdr) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin a and verapamil on mdr leukemia t‐cells
- 15 July 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (1) , 67-72
- https://doi.org/10.1002/ijc.2910460114
Abstract
A novel fluorometric microculture cytotoxicity assay (FMCA), based on measurements of fluorescein diacetate (FDA) hydrolysis and DNA staining by Hoechst 33342, was used for drug sensitivity testing and detection of resistance reversal in acute lymphoblastic leukemia (ALL) cell lines. The 72‐hr assay was found to be sensitive, reproducible and linearly related to the number of viable cells within a broad range of cell concentrations. At clinically achievable drug concentrations, the calcium channel blocker Verapamil (ver) and the immunosuppressant Cyclosporin A (csA) were found to partly reverse acquired Vincristine (vcr) resistance in multidrug resistant (MDR) T‐ALL LI00 cells with little or no effect on the drug‐sensitive parental LO cell line. By combining the fluorometric indices, we found that low concentrations of csA were growth‐inhibitory, whereas higher concentrations (>IOμg/ml) were progressively cytotoxic for drug‐sensitive LO cells. In MDR LlOO cells, on the other hand, csA produced significant cell kill even at low drug concentrations. Ver had no effects on sensitive LO cells but showed considerable cytotoxic action towards MDR LIOO cells. There was no apparent relationship between drug reversal of vcr resistance and the cytotoxic actions of the drug per se since the calcium channel blocker diltiazem (dil) significantly potentiated the actions of vcr on MDR LIOO cells without being more toxic to these cells (compared to vcr‐sensitive LO cells).This publication has 23 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Mechanisms for acquired cytotoxic drug resistance in human small cell lung cancer and the potential utilization of resistance modifiers — A review with focus on in vitro studiesLung Cancer, 1990
- Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistanceInternational Journal of Cancer, 1988
- Use of DiO-C5-3 to improve Hoechst 33342 uptake, resolution of DNA content, and survival of CHO cellsExperimental Cell Research, 1988
- Use of fluorescent dyes as molecular probes for the study of multidrug resistanceExperimental Cell Research, 1988
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazemMedical and Pediatric Oncology, 1985
- Reversal of Adriamycin Resistance by Verapamil in Human Ovarian CancerScience, 1984
- ANTIPROLIFERATIVE ACTIVITY OF CYCLOSPORIN A ON HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELL LINEThe Lancet, 1981